Compare Royal Bank of Canada (RY) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Bank of Canada vs Tenet Healthcare Corporation — how do they compare? Royal Bank of Canada trades at $206.91 (market cap $289.01B), while Tenet Healthcare Corporation trades at $269.36 (market cap $20.86B). The key difference: Royal Bank of Canada is far larger — about 13.9× Tenet Healthcare Corporation's market cap, and Royal Bank of Canada pays a 2.43% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| RY | THC | |
|---|---|---|
Market Cap | $289.01B | $20.86B |
Sector | Financials | Health |
52-Week High | $217.87 | $280.77 |
52-Week Low | $143.64 | $161.37 |
Dividend Yield | 2.43% | — |
Enterprise Value | — | $31.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Royal Bank of Canada (RY) trades at $209.00, down 0.76% on the day, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings of $3.07 per share, beating estimates of $2.89, continuing a trend of quarterly beats. Revenue growth accelerated to $66.53 billion in 2025, with net income margin improving to 32.01% and ROE at 17.2%. Recent corporate actions include dividend declarations of $1.76 per share payable in November 2026.
RY demonstrates solid fundamental strength with consistent earnings outperformance and robust profitability metrics. The stock faces valuation concerns with a P/E of 18.23 and P/S of 5.69, while analyst sentiment remains mixed with 43% buy ratings versus 53% hold. Key risks include stretched bank valuations and macroeconomic sensitivity, but the company's diversified business model and record earnings provide stability for long-term investors.
Tenet Healthcare (THC) trades at $259.06, down 2.26% today, with a bearish technical signal but strong fundamentals. The stock exhibits robust profitability with an 82.83% gross margin and 53.31% ROE, supported by three consecutive quarterly EPS beats. Recent news includes a $2.0 billion senior notes offering for refinancing and participation in the Wells Fargo Healthcare Conference.
Outlook remains positive given analyst consensus of 81.25% buy ratings and a $281.44 price target, implying 8.6% upside. Risks include debt refinancing execution and healthcare regulatory pressures, but earnings momentum and valuation multiples below industry averages present a compelling opportunity for value investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
